SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-15.7%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$691M
AUM Growth
+$691M
(-9.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-2.65%
Top 10 Holdings %
Top 10 Hldgs %
39.75%
Holding
133
New
22
Increased
30
Reduced
31
Closed
35
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$29.8M |
| 2 |
AstraZeneca
AZN
|
$19.6M |
| 3 |
Palo Alto Networks
PANW
|
$17.5M |
| 4 |
Ituran Location and Control
ITRN
|
$14.6M |
| 5 |
Viatris
VTRS
|
$9.65M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$44.9M |
| 2 |
Merck
MRK
|
$23.5M |
| 3 |
GSK
GSK
|
$21.2M |
| 4 |
Microsoft
MSFT
|
$8.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$8.53M |
Sector Composition
| 1 | Healthcare | 77.38% |
| 2 | Technology | 15.67% |
| 3 | Industrials | 3.75% |
| 4 | Consumer Discretionary | 0.67% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sangamo Therapeutics
SGMO
$157M
| $3.9M | 0.44% | +340,000 | New | +$3.9M |
|
52
Sutro Biopharma
STRO
$72.7M
| $3.68M | 0.41% | 407,889 +132,889 | +48% | +$1.2M |
|
53
Ascendis Pharma
ASND
$11.8B
| $3.65M | 0.41% | 58,273 -34,400 | -37% | -$2.16M |
|
|
NEOS
54
DELISTED
Neos Therapeutics, Inc
NEOS
| $3.63M | 0.41% | 2,201,697 +1,370,000 | +165% | +$2.26M |
|
55
Krystal Biotech
KRYS
$4.27B
| $3.63M | 0.41% | +174,625 | New | +$3.63M |
|
56
Q32 Bio
QTTB
$20.9M
| $3.6M | 0.41% | 161,000 -84,104 | -34% | -$1.88M |
|
57
Evoke Pharma
EVOK
$8.49M
| $3.5M | 0.39% | 1,410,946 | – | – |
|
58
Arvinas
ARVN
$568M
| $3.48M | 0.39% | 271,053 +31,053 | +13% | +$399K |
|
59
SPDR S&P Biotech ETF
XBI
$5.07B
| $3.23M | 0.36% | +45,000 | New | +$3.23M |
|
60
Agios Pharmaceuticals
AGIO
$2.19B
| $3.11M | 0.35% | +67,500 | New | +$3.11M |
|
|
KDMN
61
DELISTED
Kadmon Holdings, Inc.
KDMN
| $3.1M | 0.35% | 1,490,000 | – | – |
|
62
Allogene Therapeutics
ALLO
$251M
| $3.06M | 0.34% | +113,437 | New | +$3.06M |
|
63
AC Immune
ACIU
$205M
| $2.94M | 0.33% | 310,613 -192,950 | -38% | -$1.82M |
|
|
PTLA
64
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.87M | 0.32% | 147,000 | – | – |
|
65
Xenon Pharmaceuticals
XENE
$2.98B
| $2.84M | 0.32% | 449,484 +70,000 | +18% | +$442K |
|
|
DCPH
66
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2.42M | 0.27% | 115,033 +5,000 | +5% | +$105K |
|
|
CBIO
67
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $2.38M | 0.27% | 251,013 | – | – |
|
|
TBIO
68
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $2.32M | 0.26% | 309,400 +32,761 | +12% | +$246K |
|
69
VistaGen Therapeutics
VTGN
$102M
| $2.21M | 0.25% | 1,473,918 -200,000 | -12% | -$300K |
|
70
Kornit Digital
KRNT
$669M
| $2.12M | 0.24% | +30,342 | New | +$2.12M |
|
71
Immatics
IMTX
$619M
| $2.05M | 0.23% | +200,000 | New | +$2.05M |
|
72
Abeona Therapeutics
ABEO
$350M
| $1.93M | 0.22% | 270,036 -66,903 | -20% | -$478K |
|
|
WHWK
73
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.92M | 0.22% | 1,131,819 | – | – |
|
74
Larimar Therapeutics
LRMR
$310M
| $1.88M | 0.21% | 380,000 -50,000 | -12% | -$248K |
|
|
ALNA
75
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $1.88M | 0.21% | 345,199 +50,000 | +17% | +$272K |
|